ea0040p22 | (1) | ESEBEC2016
Fabiana Pani
, Mario Scartozzi
, Francesco Atzori
, Germana Baghino
, Francesco Boi
, Luciana Tanca
, Teresa Ionta Maria
, Stefano Mariotti
Background: The development of thyroid dysfunction is a frequent side effect associated to sunitinib therapy but scanty data are available on thyroid function on long-term sunitinib-treated patients.Objective: Prospective evaluation of 28 patients suffering from mRCC treated with sunitinib, enrolled between September 2013 and October 2015. 28 patients (24 men and 3 women (median age 57.7, range 5177)) with comparable tumor staging, normal thyroid f...